LIPODOX 50 (Sun Pharma Global FZE)
Welcome to the PulseAid listing for the LIPODOX 50 drug offered from Sun Pharma Global FZE. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sun Pharma Global FZE |
| NON-PROPRIETARY NAME: | Doxorubicin Hydrochloride |
| SUBSTANCE NAME: | DOXORUBICIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTABLE, LIPOSOMAL |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| START MARKETING DATE: | 2012-02-09 |
| END MARKETING DATE: | 0000-00-00 |
LIPODOX 50 HUMAN PRESCRIPTION DRUG Details:
| Item Description | LIPODOX 50 from Sun Pharma Global FZE |
| LABELER NAME: | Sun Pharma Global FZE |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2012-02-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47335-083_52e7503a-14bc-4964-8680-6302c1c70a6b |
| PRODUCT NDC: | 47335-083 |
| APPLICATION NUMBER: | |
Other DOXORUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
